Thus, our study reveals a novel role for pathogenic LRRK2 related to proper centrosome functioning, which may not only contribute to neurodegeneration, but may also account for some early manifestations of the disease and the increased incidence of cancer seen in PD patients. Here, LRRK2 is linked to Parkinson disease.